12. Abbildungsverzeichnis – Prevention of Skin Cancer

Version 2.1 · August 2021 · AWMF 032/052OL
Leitlinienprogramm Onkologie · Deutsche Krebsgesellschaft · Deutsche Krebshilfe · AWMF

Four-field panel model of the different forms of prevention according to Kühnlein et al., 2010

Prevention matrix: Different dimensions of prevention measures (ADP, 2020)

Age-specific melanoma incidence rates in 2014 differentiated by sex (Center for Cancer Registry Data at the Robert Koch Institute, 2019).

Time course of incidence rates in Saarland and Germany (smoothed; 3-years-floating means; old European standard; SL=Saarland, GER=Germany) (Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V., 2019; Saarland; Zentrum für Krebsregisterdaten am Robert Koch-Institut, 2019).

Age-standardized melanoma incidence in Europe in 2018 (world standard).

Age-standardized melanoma mortality in Europe in 2018 (world standard) (International Agency for Research on Cancer, 2010b).

Age-specific incidence rates of non-melanocytic skin cancer in 2014 differentiated by sex (Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V., 2019).

Time course of incidence rates in Saarland and Germany (smoothed; 3-years-floating means; old European standard; SL=Saarland, GER=Germany) (Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V., 2019; Saarland).

Time course of incidence (EASR; age standardized according to European standard) for malignant melanoma in Schleswig-Holstein (dashed line) and Germany (solid line; each floating means) (Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V., 2019).

Time course of incidence (EASR; age standardized according to European standard) for non-melanotic skin tumors in Schleswig-Holstein (dashed line) and Germany (solid line; each floating means) (Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V., 2019).

Age-standardized mortality (per 100,000 women or men) of melanocytic (ICD-10 C43) and nonmelanocytic (ICD-10 C44) skin cancer by sex (Hübner et al., 2019, p. 989)

Age-standardized mortality (per 100,000 population) of melanocytic (ICD-10 C43) and non-melanocytic (ICD-10 C44) skin cancer for both sexes. Solid lines represent modeled trends in each case. Circles denote annual values in which these change. Vertical lines mark the onset of changes in care that should have an impact on mortality (Hübner et al., 2019, p. 919)

Course of a cancer disease with effective screening (Becker, 2002)

Schematic representation of the multidisciplinary two-stage approach to population-based screening for skin cancer.